Annual D&A
$1.37 B
+$323.00 M+30.95%
31 December 2023
Summary:
Novo Nordisk A/S annual depreciation & amortization is currently $1.37 billion, with the most recent change of +$323.00 million (+30.95%) on 31 December 2023. During the last 3 years, it has risen by +$485.16 million (+55.04%). NVO annual D&A is now at all-time high.NVO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$352.45 M
-$920.45 M-72.31%
30 September 2024
Summary:
Novo Nordisk A/S quarterly depreciation & amortization is currently $352.45 million, with the most recent change of -$920.45 million (-72.31%) on 30 September 2024. Over the past year, it has dropped by -$15.82 million (-4.30%). NVO quarterly D&A is now -72.31% below its all-time high of $1.27 billion, reached on 30 June 2024.NVO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.48 B
-$15.82 M-0.63%
30 September 2024
Summary:
Novo Nordisk A/S TTM depreciation & amortization is currently $2.48 billion, with the most recent change of -$15.82 million (-0.63%) on 30 September 2024. Over the past year, it has increased by +$1.22 billion (+96.70%). NVO TTM D&A is now -0.63% below its all-time high of $2.49 billion, reached on 30 June 2024.NVO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | -4.3% | +96.7% |
| 3 y3 years | +55.0% | +72.2% | +202.5% |
| 5 y5 years | +119.8% | +14.1% | +175.2% |
NVO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.0% | -72.3% | +72.2% | -0.6% | +202.5% |
| 5 y | 5 years | at high | +119.8% | -72.3% | +119.8% | -0.6% | +202.5% |
| alltime | all time | at high | +1521.1% | -72.3% | +282.0% | -0.6% | +2230.3% |
Novo Nordisk A/S Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $352.45 M(-72.3%) | $2.48 B(-0.6%) |
| June 2024 | - | $1.27 B(+199.9%) | $2.49 B(+61.7%) |
| Mar 2024 | - | $424.45 M(-1.1%) | $1.54 B(+12.9%) |
| Dec 2023 | $1.37 B(+30.9%) | $428.96 M(+16.5%) | $1.37 B(+8.5%) |
| Sept 2023 | - | $368.27 M(+14.5%) | $1.26 B(+10.3%) |
| June 2023 | - | $321.51 M(+29.7%) | $1.14 B(+9.6%) |
| Mar 2023 | - | $247.90 M(-23.1%) | $1.04 B(-0.1%) |
| Dec 2022 | $1.04 B(+8.9%) | $322.46 M(+28.6%) | $1.04 B(-1.1%) |
| Sept 2022 | - | $250.76 M(+13.2%) | $1.05 B(+4.6%) |
| June 2022 | - | $221.52 M(-11.0%) | $1.01 B(+2.5%) |
| Mar 2022 | - | $248.91 M(-25.4%) | $984.39 M(+2.7%) |
| Dec 2021 | $958.70 M(+8.8%) | $333.58 M(+62.9%) | $958.70 M(+17.0%) |
| Sept 2021 | - | $204.74 M(+3.8%) | $819.48 M(-15.6%) |
| June 2021 | - | $197.17 M(-11.7%) | $970.47 M(+2.8%) |
| Mar 2021 | - | $223.22 M(+14.9%) | $944.37 M(+7.1%) |
| Dec 2020 | $881.48 M(+3.8%) | $194.35 M(-45.4%) | $881.48 M(-2.2%) |
| Sept 2020 | - | $355.73 M(+107.9%) | $900.90 M(+5.5%) |
| June 2020 | - | $171.07 M(+6.7%) | $854.05 M(+0.7%) |
| Mar 2020 | - | $160.33 M(-25.0%) | $848.14 M(-0.1%) |
| Dec 2019 | $848.83 M(+36.5%) | $213.78 M(-30.8%) | $848.83 M(-5.8%) |
| Sept 2019 | - | $308.88 M(+87.0%) | $900.78 M(+27.3%) |
| June 2019 | - | $165.15 M(+2.6%) | $707.57 M(+6.9%) |
| Mar 2019 | - | $161.02 M(-39.4%) | $662.01 M(+6.5%) |
| Dec 2018 | $621.75 M(+28.4%) | $265.73 M(+129.7%) | $621.75 M(+29.4%) |
| Sept 2018 | - | $115.67 M(-3.3%) | $480.52 M(-2.4%) |
| June 2018 | - | $119.59 M(-1.0%) | $492.41 M(-2.2%) |
| Mar 2018 | - | $120.76 M(-3.0%) | $503.68 M(+4.0%) |
| Dec 2017 | $484.35 M(+2.1%) | $124.50 M(-2.4%) | $484.35 M(-7.4%) |
| Sept 2017 | - | $127.56 M(-2.5%) | $523.00 M(+3.9%) |
| June 2017 | - | $130.86 M(+29.0%) | $503.31 M(+4.0%) |
| Mar 2017 | - | $101.43 M(-37.8%) | $483.77 M(+1.9%) |
| Dec 2016 | $474.60 M(+7.8%) | $163.16 M(+51.3%) | $474.60 M(+2.7%) |
| Sept 2016 | - | $107.86 M(-3.1%) | $462.16 M(+2.8%) |
| June 2016 | - | $111.32 M(+20.7%) | $449.68 M(+4.1%) |
| Mar 2016 | - | $92.26 M(-38.8%) | $432.06 M(-1.9%) |
| Dec 2015 | $440.22 M | $150.72 M(+58.0%) | $440.22 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $95.39 M(+1.8%) | $456.38 M(-19.0%) |
| June 2015 | - | $93.70 M(-6.7%) | $563.48 M(-4.9%) |
| Mar 2015 | - | $100.42 M(-39.8%) | $592.48 M(-3.3%) |
| Dec 2014 | $612.67 M(+22.9%) | $166.88 M(-17.6%) | $612.67 M(+37.4%) |
| Sept 2014 | - | $202.48 M(+65.0%) | $445.79 M(+83.2%) |
| June 2014 | - | $122.70 M(+1.7%) | $243.31 M(+101.7%) |
| Mar 2014 | - | $120.61 M(-7.3%) | $120.61 M(-72.5%) |
| Dec 2013 | $498.39 M(+7.2%) | - | - |
| Dec 2012 | $465.06 M(-9.0%) | - | - |
| Dec 2011 | $511.28 M(+16.4%) | - | - |
| Dec 2010 | $439.19 M(-8.0%) | $130.11 M(+20.3%) | $439.19 M(-0.5%) |
| Sept 2010 | - | $108.18 M(+16.5%) | $441.31 M(-6.0%) |
| June 2010 | - | $92.87 M(-14.0%) | $469.71 M(-2.0%) |
| Mar 2010 | - | $108.03 M(-18.3%) | $479.08 M(+0.3%) |
| Dec 2009 | $477.42 M(-1.1%) | $132.23 M(-3.2%) | $477.42 M(+38.3%) |
| Sept 2009 | - | $136.58 M(+33.6%) | $345.19 M(+65.5%) |
| June 2009 | - | $102.23 M(-3.9%) | $208.61 M(+96.1%) |
| Mar 2009 | - | $106.37 M | $106.37 M |
| Dec 2008 | $482.62 M(-12.9%) | - | - |
| Dec 2007 | $553.92 M(+53.6%) | - | - |
| Dec 2006 | $360.68 M(+11.9%) | - | - |
| Dec 2005 | $322.20 M(+1.2%) | - | - |
| Dec 2004 | $318.50 M(+28.7%) | - | - |
| Dec 2003 | $247.53 M(+46.2%) | - | - |
| Dec 2002 | $169.32 M(+30.7%) | - | - |
| Dec 2001 | $129.52 M(+1.0%) | - | - |
| Dec 2000 | $128.25 M(-5.5%) | - | - |
| Dec 1999 | $135.72 M(-8.0%) | - | - |
| Dec 1998 | $147.55 M(-14.8%) | - | - |
| Dec 1997 | $173.21 M(-5.9%) | - | - |
| Dec 1996 | $184.13 M(-9.5%) | - | - |
| Dec 1995 | $203.43 M(+22.3%) | - | - |
| Dec 1994 | $166.28 M(+34.7%) | - | - |
| Dec 1993 | $123.41 M(+7.1%) | - | - |
| Dec 1992 | $115.18 M(+24.1%) | - | - |
| Dec 1991 | $92.79 M(+10.1%) | - | - |
| Dec 1990 | $84.30 M | - | - |
FAQ
- What is Novo Nordisk A/S annual depreciation & amortization?
- What is the all time high annual D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual D&A year-on-year change?
- What is Novo Nordisk A/S quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly D&A year-on-year change?
- What is Novo Nordisk A/S TTM depreciation & amortization?
- What is the all time high TTM D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM D&A year-on-year change?
What is Novo Nordisk A/S annual depreciation & amortization?
The current annual D&A of NVO is $1.37 B
What is the all time high annual D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual depreciation & amortization is $1.37 B
What is Novo Nordisk A/S annual D&A year-on-year change?
Over the past year, NVO annual depreciation & amortization has changed by +$323.00 M (+30.95%)
What is Novo Nordisk A/S quarterly depreciation & amortization?
The current quarterly D&A of NVO is $352.45 M
What is the all time high quarterly D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly depreciation & amortization is $1.27 B
What is Novo Nordisk A/S quarterly D&A year-on-year change?
Over the past year, NVO quarterly depreciation & amortization has changed by -$15.82 M (-4.30%)
What is Novo Nordisk A/S TTM depreciation & amortization?
The current TTM D&A of NVO is $2.48 B
What is the all time high TTM D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM depreciation & amortization is $2.49 B
What is Novo Nordisk A/S TTM D&A year-on-year change?
Over the past year, NVO TTM depreciation & amortization has changed by +$1.22 B (+96.70%)